Procter & Gamble Financial Statements (PG)

Procter & Gamblesmart-lab.ru   FY2021 FY2022 FY2023 FY2024 FY2025   LTM ?
Report date 06.08.2021 05.08.2022 04.08.2023 05.08.2024 04.08.2025   24.04.2026
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 76 118 80 187 82 006 84 039 84 284   86 718
Operating Income, bln rub 17 986 17 813 18 134 18 545 20 451   20 153
EBITDA, bln rub ? 20 852 21 241 21 771 22 582 23 921   23 261
Net profit, bln rub ? 14 306 14 742 14 653 14 879 15 974   16 665
OCF, bln rub ? 18 371 16 723 16 848 19 846 17 817   19 410
CAPEX, bln rub ? 2 787 3 156 3 062 3 322 3 773   4 382
FCF, bln rub ? 15 584 13 567 13 786 16 524 14 044   15 028
Dividend payout, bln rub 8 263 8 770 8 999 9 312 9 872   10 176
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 57.8% 59.5% 61.4% 62.6% 61.8%   61.1%
OPEX, bln rub 21 024 20 217 21 112 24 646 22 669   23 490
Cost of production, bln rub 37 108 42 157 42 760 40 848 41 164   43 074
R&D, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Interest expenses, bln rub 502.0 439.0 756.0 925.0 907.0   852.0
Assets, bln rub 119 307 117 208 120 829 122 370 125 231   128 379
Net Assets, bln rub ? 46 378 46 589 46 777 50 286 52 012   54 505
Debt, bln rub 32 838 32 293 35 424 33 369 35 463   37 026
Cash, bln rub 10 288 7 214 8 246 9 482 9 556   12 306
Net debt, bln rub 22 550 25 079 27 178 23 887 25 907   24 720
Ordinary share price, rub 134.9 143.8 151.7 159.3   140.0
Number of ordinary shares, mln 2 514 2 457 2 368 2 360 2 454   2 417
Market cap, bln rub 339 246 353 292 359 351 0 391 035   338 407
EV, bln rub ? 361 796 378 371 386 529 23 887 416 942   363 127
Book value, bln rub -18 188 -16 790 -17 665 -12 064 -11 548   -8 385
EPS, rub ? 5.69 6.00 6.19 6.30 6.51   6.90
FCF/share, rub 6.20 5.52 5.82 7.00 5.72   6.22
BV/share, rub -7.23 -6.83 -7.46 -5.11 -4.71   -3.47
EBITDA margin, % ? 27.4% 26.5% 26.5% 26.9% 28.4%   26.8%
Net margin, % ? 18.8% 18.4% 17.9% 17.7% 19.0%   19.2%
FCF yield, % ? 4.59% 3.84% 3.84% 3.59%   4.44%
ROE, % ? 30.8% 31.6% 31.3% 29.6% 30.7%   30.6%
ROA, % ? 12.0% 12.6% 12.1% 12.2% 12.8%   13.0%
P/E ? 23.7 24.0 24.5 0.00 24.5   20.3
P/FCF 21.8 26.0 26.1 0.00 27.8   22.5
P/S ? 4.46 4.41 4.38 0.00 4.64   3.90
P/BV ? -18.7 -21.0 -20.3 0.00 -33.9   -40.4
EV/EBITDA ? 17.4 17.8 17.8 1.06 17.4   15.6
Debt/EBITDA 1.08 1.18 1.25 1.06 1.08   1.06
R&D/CAPEX, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
CAPEX/Revenue, % 3.66% 3.94% 3.73% 3.95% 4.48%   5.05%
Procter & Gamble shareholders